These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18803938)

  • 1. Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation.
    Asagami T; Holmes TH; Reaven G
    Metabolism; 2008 Oct; 57(10):1355-60. PubMed ID: 18803938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders.
    Acién P; Quereda F; Matallín P; Villarroya E; López-Fernández JA; Acién M; Mauri M; Alfayate R
    Fertil Steril; 1999 Jul; 72(1):32-40. PubMed ID: 10428145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.
    Eldar-Geva T; Spitz IM; Groome NP; Margalioth EJ; Homburg R
    Hum Reprod; 2001 Dec; 16(12):2552-6. PubMed ID: 11726573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
    Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
    J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.
    Falcone T; Finegood DT; Fantus IG; Morris D
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1653-7. PubMed ID: 2146285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome.
    Grulet H; Hecart AC; Delemer B; Gross A; Sulmont V; Leutenegger M; Caron J
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):621-6. PubMed ID: 8334748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
    Olszanecka-Glinianowicz M; Banaś M; Zahorska-Markiewicz B; Kuglin D; Mokrzycka J; Mentel A
    Endokrynol Pol; 2005; 56(6):921-6. PubMed ID: 16821212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indices of insulin sensitivity, beta cell function and serum proinsulin levels in the polycystic ovary syndrome.
    Panidis D; Macut D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Spanos N; Petakov M; Bjekic J; Damjanovic S
    Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):99-105. PubMed ID: 16460870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
    Azadi-Yazdi M; Karimi-Zarchi M; Salehi-Abargouei A; Fallahzadeh H; Nadjarzadeh A
    J Hum Nutr Diet; 2017 Jun; 30(3):275-283. PubMed ID: 28466507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
    Mejia-Montilla J; Álvarez-Mon M; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Suarez-Torres I; Bravo-Henríquez A
    Endocrinol Nutr; 2015 Jan; 62(1):31-7. PubMed ID: 25458401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters.
    Chapman IM; Wittert GA; Norman RJ
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):175-81. PubMed ID: 9135699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Study of Insulin Sensitivity and Resistance and Their Correlation with Androgens in Lean and Obese Women with Polycystic Ovary Syndrome.
    Misra S; Gada J; Dhole C; Varthakavi P; Bhagwat N
    Reprod Sci; 2024 Mar; 31(3):754-763. PubMed ID: 37848646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
    Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
    Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome.
    Zhang H; Wang W; Zhao J; Jiao P; Zeng L; Zhang H; Zhao Y; Shi L; Hu H; Luo L; Fukuzawa I; Li D; Li R; Qiao J
    Front Endocrinol (Lausanne); 2022; 13():1085656. PubMed ID: 36699018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.